Gene · 25939
Papers2,857
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,857
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modeling calcific aortic valve disease with engineered human valve tissues identifies SAMHD1 as a therapeutic target. | Biomaterials | 2027 | 42501740 | PubTator, text mining | PubMed |
| Nucleotide metabolic reprogramming: a "double-edged sword" in obesity-related inflammation-from metabolic adaptation to pathological imbalance. | J Physiol Biochem | 2026 | 42799975 | PubTator, text mining | PubMed |
| The interaction between HIV-1 central polypurine tract and host SAMHD1 dNTPase during HIV-1 vector transduction in human primary nondividing monocyte-derived macrophages. | Virus Genes | 2026 | 42722809 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics define eosinophil heterogeneity during influenza A virus-induced exacerbation of fungal allergic asthma in C57BL/6 mice. | J Leukoc Biol | 2026 | 42707006 | PubTator, text mining | PubMed |
| Iterative genetic testing identifies SAMHD1 deficiency caused by a homozygous balanced translocation. | J Hum Immun | 2026 | 42657394 | PubTator, text mining | PubMed |
| p21 (CDKN1A) Is the Major Driver of Sulforaphane-Mediated Reduction in SAMHD1 T592 Phosphorylation in Macrophages. | Biomolecules | 2026 | 42650879 | PubTator, text mining | PubMed |
| SAMHD1 enhances HIV-1-induced glycolysis in monocytic cells through hexokinase 2 upregulation. | bioRxiv | 2026 | 42619998 | PubTator, text mining | PubMed |
| Type I Interferonopathies in the Differential Diagnosis of Vasculitis: A Comprehensive Review. | J Vis Exp | 2026 | 42611810 | PubTator, text mining | PubMed |
| Transition Metal Activation Reframes SAMHD1 Regulation. | ACS Chem Biol | 2026 | 42457644 | PubTator, text mining | PubMed |
| TLR3 activation of microglia-containing cerebral organoid induces antiviral factors against HIV-1 infection. | Front Pharmacol | 2026 | 42453569 | PubTator, text mining | PubMed |
| Entosis remodels the immune microenvironment of osteosarcoma by regulating macrophage polarization: An integrated study based on multi-omics data and in vitro experiments. | Transl Oncol | 2026 | 42407378 | PubTator, text mining | PubMed |
| Early brain-penetrant immunotherapy reverses interferon signature and improves motor outcome in a case of ADAR1-related Aicardi-Goutières syndrome. | Clin Transl Immunology | 2026 | 42376186 | PubTator, text mining | PubMed |
| A toxic STING-SAMHD1 axis drives replication stress in progeria and cancer cells. | Nucleic Acids Res | 2026 | 42306943 | PubTator, text mining | PubMed |
| Genetic and transcriptomic signatures of host control in HIV-1 infection. | Retrovirology | 2026 | 42304468 | PubTator, text mining | PubMed |
| A genomic structural equation modelling analysis of the shared genetic architecture of the aging spine. | Eur Spine J | 2026 | 42237046 | PubTator, text mining | PubMed |
| Fingolimod increases cellular resistance to HIV-1 infection and limits viral reservoir size in peripheral CD4+ T-cells. | PLoS Pathog | 2026 | 42234672 | PubTator, text mining | PubMed |
| Functionalist Oncology to Model the Contextuality of Dynamics and Treatment in Acute Myeloid Leukaemia. | IET Syst Biol | 2026 | 42224255 | PubTator, text mining | PubMed |
| A homozygous splice-site variant in SAMHD1 shows variable expressivity of Aicardi-Goutières syndrome type 5: a case report and literature review. | Front Pediatr | 2026 | 42221009 | PubTator, text mining | PubMed |
| Human Immunodeficiency Virus Type 2 Vpx-mediated Degradation of TASOR Activates Innate Immune Sensing of Nucleic Acids in Infected Cells. | J Mol Biol | 2026 | 42190982 | PubTator, text mining | PubMed |
| A cell-impermeable kinase inhibitor uncovers outside-in signaling pathways that promote HIV-1 infection. | J Virol | 2026 | 42112903 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25939/papers